Archer Materials Ltd

Founded in 2007, Archer Materials initially began its journey focusing on material science and the development of advanced technologies for the electronics industry. Over the years, the company expanded its research to include the high-tech fields of quantum computing and energy storage solutions. By 2019, it had pivoted completely to its current product suite. Driving the company’s value has been technical achievements recorded with both products. With 12CQ, early milestones included demonstrating quantum information detection on-chip and advancing nanofabrication compatible with industry semiconductor processes. More recent progress has seen Archer achieve key technical steps such as single-electron isolation, enhanced spin control and extended coherence times at room temperature – all critical steps towards building a functional quantum device. With Biochip, Archer has already produced an alpha prototype capable of clinically accurate blood potassium sensing using very small sample volumes, meeting standards that could make it viable for point-of-care or home diagnostics. Next steps include completing a beta prototype in 2026, which will be key for pursuing commercial partnerships with MedTech firms. Archer’s technical milestones over the years include working with strategic fabrication partners and research institutes (including IMEC, CSIRO and Emergence Quantum), miniaturising its Biochip design for foundry manufacturing, and progressing both device architecture and CMOS integration for commercial scalability.